Prostate Cancer Drugs Market Report

Global Prostate Cancer Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：232
  • REPORT CODE：GMM826080
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Prostate Cancer Drugs market report explains the definition, types, applications, major countries, and major players of the Prostate Cancer Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Johnson & Johnson

    • Boehringer Ingelheim

    • Ferring Pharmaceutical

    • Teva Pharmaceutical

    • Bayer HealthCare

    • Astra Zeneca

    • Endo Pharmaceuticals

    • AbbVie

    • Janssen Pharmaceuticals

    • Spectrum Pharmaceuticals

    • Novartis

    • Foresee Pharmaceuticals

    • Astellas Pharma

    • Tokai Pharmaceuticals

    • Takeda Pharmaceuticals

    • GlaxoSmithKline

    • Amgen

    • Sanofi

    • BMS

    • Northwest Biotherapeutics

    • Merck Group

    By Type:

    • Hormonal Therapy

    • Chemotherapy

    • Immunotherapy

    • Targeted Therapy

    By End-User:

    • Clinics

    • Hospitals

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Prostate Cancer Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Prostate Cancer Drugs Outlook to 2028- Original Forecasts

    • 2.2 Prostate Cancer Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Prostate Cancer Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Prostate Cancer Drugs Market- Recent Developments

    • 6.1 Prostate Cancer Drugs Market News and Developments

    • 6.2 Prostate Cancer Drugs Market Deals Landscape

    7 Prostate Cancer Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Prostate Cancer Drugs Key Raw Materials

    • 7.2 Prostate Cancer Drugs Price Trend of Key Raw Materials

    • 7.3 Prostate Cancer Drugs Key Suppliers of Raw Materials

    • 7.4 Prostate Cancer Drugs Market Concentration Rate of Raw Materials

    • 7.5 Prostate Cancer Drugs Cost Structure Analysis

      • 7.5.1 Prostate Cancer Drugs Raw Materials Analysis

      • 7.5.2 Prostate Cancer Drugs Labor Cost Analysis

      • 7.5.3 Prostate Cancer Drugs Manufacturing Expenses Analysis

    8 Global Prostate Cancer Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Prostate Cancer Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Prostate Cancer Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Prostate Cancer Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Prostate Cancer Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prostate Cancer Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Prostate Cancer Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Prostate Cancer Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Prostate Cancer Drugs Consumption (2017-2022)

      • 10.2.2 Canada Prostate Cancer Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Prostate Cancer Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.2 UK Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.3 Spain Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.5 France Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.6 Italy Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.8 Finland Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.9 Norway Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.11 Poland Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.12 Russia Prostate Cancer Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Prostate Cancer Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.2 Japan Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.3 India Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Prostate Cancer Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Prostate Cancer Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Prostate Cancer Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Prostate Cancer Drugs Consumption (2017-2022)

      • 10.5.3 Chile Prostate Cancer Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Prostate Cancer Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Prostate Cancer Drugs Consumption (2017-2022)

      • 10.5.6 Peru Prostate Cancer Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Prostate Cancer Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Prostate Cancer Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Prostate Cancer Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Prostate Cancer Drugs Consumption (2017-2022)

      • 10.6.3 Oman Prostate Cancer Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Prostate Cancer Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Prostate Cancer Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Prostate Cancer Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Prostate Cancer Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Prostate Cancer Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Prostate Cancer Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Prostate Cancer Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Prostate Cancer Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Prostate Cancer Drugs Consumption (2017-2022)

    11 Global Prostate Cancer Drugs Competitive Analysis

    • 11.1 Johnson & Johnson

      • 11.1.1 Johnson & Johnson Company Details

      • 11.1.2 Johnson & Johnson Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Johnson & Johnson Prostate Cancer Drugs Main Business and Markets Served

      • 11.1.4 Johnson & Johnson Prostate Cancer Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Boehringer Ingelheim

      • 11.2.1 Boehringer Ingelheim Company Details

      • 11.2.2 Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Boehringer Ingelheim Prostate Cancer Drugs Main Business and Markets Served

      • 11.2.4 Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Ferring Pharmaceutical

      • 11.3.1 Ferring Pharmaceutical Company Details

      • 11.3.2 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Ferring Pharmaceutical Prostate Cancer Drugs Main Business and Markets Served

      • 11.3.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Teva Pharmaceutical

      • 11.4.1 Teva Pharmaceutical Company Details

      • 11.4.2 Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Teva Pharmaceutical Prostate Cancer Drugs Main Business and Markets Served

      • 11.4.4 Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Bayer HealthCare

      • 11.5.1 Bayer HealthCare Company Details

      • 11.5.2 Bayer HealthCare Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Bayer HealthCare Prostate Cancer Drugs Main Business and Markets Served

      • 11.5.4 Bayer HealthCare Prostate Cancer Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Astra Zeneca

      • 11.6.1 Astra Zeneca Company Details

      • 11.6.2 Astra Zeneca Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Astra Zeneca Prostate Cancer Drugs Main Business and Markets Served

      • 11.6.4 Astra Zeneca Prostate Cancer Drugs Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Endo Pharmaceuticals

      • 11.7.1 Endo Pharmaceuticals Company Details

      • 11.7.2 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Endo Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

      • 11.7.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 AbbVie

      • 11.8.1 AbbVie Company Details

      • 11.8.2 AbbVie Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 AbbVie Prostate Cancer Drugs Main Business and Markets Served

      • 11.8.4 AbbVie Prostate Cancer Drugs Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Janssen Pharmaceuticals

      • 11.9.1 Janssen Pharmaceuticals Company Details

      • 11.9.2 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Janssen Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

      • 11.9.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Spectrum Pharmaceuticals

      • 11.10.1 Spectrum Pharmaceuticals Company Details

      • 11.10.2 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

      • 11.10.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Novartis

      • 11.11.1 Novartis Company Details

      • 11.11.2 Novartis Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Novartis Prostate Cancer Drugs Main Business and Markets Served

      • 11.11.4 Novartis Prostate Cancer Drugs Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Foresee Pharmaceuticals

      • 11.12.1 Foresee Pharmaceuticals Company Details

      • 11.12.2 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Foresee Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

      • 11.12.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Astellas Pharma

      • 11.13.1 Astellas Pharma Company Details

      • 11.13.2 Astellas Pharma Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Astellas Pharma Prostate Cancer Drugs Main Business and Markets Served

      • 11.13.4 Astellas Pharma Prostate Cancer Drugs Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Tokai Pharmaceuticals

      • 11.14.1 Tokai Pharmaceuticals Company Details

      • 11.14.2 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Tokai Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

      • 11.14.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Takeda Pharmaceuticals

      • 11.15.1 Takeda Pharmaceuticals Company Details

      • 11.15.2 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

      • 11.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 GlaxoSmithKline

      • 11.16.1 GlaxoSmithKline Company Details

      • 11.16.2 GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 GlaxoSmithKline Prostate Cancer Drugs Main Business and Markets Served

      • 11.16.4 GlaxoSmithKline Prostate Cancer Drugs Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Amgen

      • 11.17.1 Amgen Company Details

      • 11.17.2 Amgen Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Amgen Prostate Cancer Drugs Main Business and Markets Served

      • 11.17.4 Amgen Prostate Cancer Drugs Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 Sanofi

      • 11.18.1 Sanofi Company Details

      • 11.18.2 Sanofi Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 Sanofi Prostate Cancer Drugs Main Business and Markets Served

      • 11.18.4 Sanofi Prostate Cancer Drugs Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 BMS

      • 11.19.1 BMS Company Details

      • 11.19.2 BMS Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 BMS Prostate Cancer Drugs Main Business and Markets Served

      • 11.19.4 BMS Prostate Cancer Drugs Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Northwest Biotherapeutics

      • 11.20.1 Northwest Biotherapeutics Company Details

      • 11.20.2 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Northwest Biotherapeutics Prostate Cancer Drugs Main Business and Markets Served

      • 11.20.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    • 11.21 Merck Group

      • 11.21.1 Merck Group Company Details

      • 11.21.2 Merck Group Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.21.3 Merck Group Prostate Cancer Drugs Main Business and Markets Served

      • 11.21.4 Merck Group Prostate Cancer Drugs Product Portfolio

      • 11.21.5 Recent Research and Development Strategies

    12 Global Prostate Cancer Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Prostate Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Prostate Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Prostate Cancer Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Prostate Cancer Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Prostate Cancer Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Prostate Cancer Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Prostate Cancer Drugs

    • Figure of Prostate Cancer Drugs Picture

    • Table Global Prostate Cancer Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Prostate Cancer Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Hormonal Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Table North America Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Figure United States Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Figure Germany Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Figure China Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Figure Brazil Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Prostate Cancer Drugs Consumption by Country (2017-2022)

    • Figure Australia Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Prostate Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Prostate Cancer Drugs Main Business and Markets Served

    • Table Johnson & Johnson Prostate Cancer Drugs Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Prostate Cancer Drugs Main Business and Markets Served

    • Table Boehringer Ingelheim Prostate Cancer Drugs Product Portfolio

    • Table Ferring Pharmaceutical Company Details

    • Table Ferring Pharmaceutical Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring Pharmaceutical Prostate Cancer Drugs Main Business and Markets Served

    • Table Ferring Pharmaceutical Prostate Cancer Drugs Product Portfolio

    • Table Teva Pharmaceutical Company Details

    • Table Teva Pharmaceutical Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Prostate Cancer Drugs Main Business and Markets Served

    • Table Teva Pharmaceutical Prostate Cancer Drugs Product Portfolio

    • Table Bayer HealthCare Company Details

    • Table Bayer HealthCare Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare Prostate Cancer Drugs Main Business and Markets Served

    • Table Bayer HealthCare Prostate Cancer Drugs Product Portfolio

    • Table Astra Zeneca Company Details

    • Table Astra Zeneca Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astra Zeneca Prostate Cancer Drugs Main Business and Markets Served

    • Table Astra Zeneca Prostate Cancer Drugs Product Portfolio

    • Table Endo Pharmaceuticals Company Details

    • Table Endo Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Endo Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

    • Table Endo Pharmaceuticals Prostate Cancer Drugs Product Portfolio

    • Table AbbVie Company Details

    • Table AbbVie Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Prostate Cancer Drugs Main Business and Markets Served

    • Table AbbVie Prostate Cancer Drugs Product Portfolio

    • Table Janssen Pharmaceuticals Company Details

    • Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

    • Table Janssen Pharmaceuticals Prostate Cancer Drugs Product Portfolio

    • Table Spectrum Pharmaceuticals Company Details

    • Table Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

    • Table Spectrum Pharmaceuticals Prostate Cancer Drugs Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Prostate Cancer Drugs Main Business and Markets Served

    • Table Novartis Prostate Cancer Drugs Product Portfolio

    • Table Foresee Pharmaceuticals Company Details

    • Table Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foresee Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

    • Table Foresee Pharmaceuticals Prostate Cancer Drugs Product Portfolio

    • Table Astellas Pharma Company Details

    • Table Astellas Pharma Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Prostate Cancer Drugs Main Business and Markets Served

    • Table Astellas Pharma Prostate Cancer Drugs Product Portfolio

    • Table Tokai Pharmaceuticals Company Details

    • Table Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tokai Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

    • Table Tokai Pharmaceuticals Prostate Cancer Drugs Product Portfolio

    • Table Takeda Pharmaceuticals Company Details

    • Table Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceuticals Prostate Cancer Drugs Main Business and Markets Served

    • Table Takeda Pharmaceuticals Prostate Cancer Drugs Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Prostate Cancer Drugs Main Business and Markets Served

    • Table GlaxoSmithKline Prostate Cancer Drugs Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Prostate Cancer Drugs Main Business and Markets Served

    • Table Amgen Prostate Cancer Drugs Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Prostate Cancer Drugs Main Business and Markets Served

    • Table Sanofi Prostate Cancer Drugs Product Portfolio

    • Table BMS Company Details

    • Table BMS Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table BMS Prostate Cancer Drugs Main Business and Markets Served

    • Table BMS Prostate Cancer Drugs Product Portfolio

    • Table Northwest Biotherapeutics Company Details

    • Table Northwest Biotherapeutics Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Northwest Biotherapeutics Prostate Cancer Drugs Main Business and Markets Served

    • Table Northwest Biotherapeutics Prostate Cancer Drugs Product Portfolio

    • Table Merck Group Company Details

    • Table Merck Group Prostate Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Group Prostate Cancer Drugs Main Business and Markets Served

    • Table Merck Group Prostate Cancer Drugs Product Portfolio

    • Figure Global Hormonal Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Prostate Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Prostate Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US